SCYNEXIS (SCYX) Priced

Biotech developing treatments for life-threatening fungal infections.

Health Care - Pharmaceuticals

IPO Performance
Latest Trade $3.40 0.00 (0.0%)
First Day Return -10.0%
Return from IPO -66.0%
 
SCYNEXIS IPO News more
  • .
IPO Data
IPO File Date 02/27/2014
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 6.2
Deal Size ($mm) 62
 
IPO Data
IPO Date 05/01/2014
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 6.2
Deal Size ($mm) $62
 
Underwriters
more
Business Overview
Biotech developing treatments for life-threatening fungal infections.
Biotech developing treatments for life-threatening fungal infections.
more
Company Data
Headquarters Durham, NC
Founded 1999
Employees 90
Website www.scynexis.com
 

Performance vs. IPO Index (IPOUSA)